Search research articles
Contact Us
Filters
Showing results (101-110 of 270) with videos related to
Page
of 27
Sort By:
Clinical Pharmacology and Therapeutics
|
February 18, 1998
A general model for time-dissociated pharmacokinetic-pharmacodynamic relationship exemplified by paclitaxel myelosuppression
M O Karlsson, V Molnar, J Bergh, et al.
British Journal of Cancer
|
January 1, 1997
Response to ICRF-159 in cell lines resistant to cleavable complex-forming topoisomerase II inhibitors
S L Davies, J Bergh, A L Harris, et al.
British Journal of Cancer
|
September 1, 1988
Estramustine binding protein and anti-proliferative effect of estramustine in human glioma cell lines
E von Schoultz, D Lundblad, J Bergh, et al.
Calcified Tissue International
|
September 6, 2003
Rodent osteoblastic cells express voltage-sensitive calcium channels lacking a gamma subunit
J J Bergh, Y Shao, K Akanbi, et al.
Carcinogenesis
|
June 1, 1994
Acquired resistance to cisplatin and doxorubicin in a small cell lung cancer cell line is correlated to elevated expression of glutathione-linked detoxification enzymes
X Y Hao, J Bergh, O Brodin, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|
February 1, 1989
Histopathological and immunohistochemical analysis of lung tumors: description of a convenient technique for use with fine needle biopsy
H Nordgren, S Nilsson, A C Runn, et al.
European Journal of Medicinal Chemistry
|
September 9, 2011
Monoamine oxidase inhibition by selected anilide derivatives
Lesetja Legoabe, Johann Kruger, Anél Petzer, et al.
Cancer
|
July 1, 1986
Serum deoxythymidine kinase in small cell carcinoma of the lung. Relation to clinical features, prognosis, and other biochemical markers
J S Gronowitz, L Steinholtz, C F Källander, et al.
Anticancer Research
|
December 31, 1997
Characterisation of the G1/S cell cycle checkpoint defect in lung carcinoma cells with different intrinsic radiosensitivities
F Sirzén, T Heiden, A Nilsson, et al.
Cancer Research
|
November 24, 2001
Increased p53 mutation frequency during tumor progression--results from a breast cancer cohort
T Norberg, S Klaar, G Kärf, et al.
Page
of 27
Search research articles
Search
Showing results (101-110 of 270) with videos related to
Sort By:
Page
of 27
Clinical Pharmacology and Therapeutics
|
February 18, 1998
A general model for time-dissociated pharmacokinetic-pharmacodynamic relationship exemplified by paclitaxel myelosuppression
M O Karlsson, V Molnar, J Bergh, et al.
British Journal of Cancer
|
January 1, 1997
Response to ICRF-159 in cell lines resistant to cleavable complex-forming topoisomerase II inhibitors
S L Davies, J Bergh, A L Harris, et al.
British Journal of Cancer
|
September 1, 1988
Estramustine binding protein and anti-proliferative effect of estramustine in human glioma cell lines
E von Schoultz, D Lundblad, J Bergh, et al.
Calcified Tissue International
|
September 6, 2003
Rodent osteoblastic cells express voltage-sensitive calcium channels lacking a gamma subunit
J J Bergh, Y Shao, K Akanbi, et al.
Carcinogenesis
|
June 1, 1994
Acquired resistance to cisplatin and doxorubicin in a small cell lung cancer cell line is correlated to elevated expression of glutathione-linked detoxification enzymes
X Y Hao, J Bergh, O Brodin, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|
February 1, 1989
Histopathological and immunohistochemical analysis of lung tumors: description of a convenient technique for use with fine needle biopsy
H Nordgren, S Nilsson, A C Runn, et al.
European Journal of Medicinal Chemistry
|
September 9, 2011
Monoamine oxidase inhibition by selected anilide derivatives
Lesetja Legoabe, Johann Kruger, Anél Petzer, et al.
Cancer
|
July 1, 1986
Serum deoxythymidine kinase in small cell carcinoma of the lung. Relation to clinical features, prognosis, and other biochemical markers
J S Gronowitz, L Steinholtz, C F Källander, et al.
Anticancer Research
|
December 31, 1997
Characterisation of the G1/S cell cycle checkpoint defect in lung carcinoma cells with different intrinsic radiosensitivities
F Sirzén, T Heiden, A Nilsson, et al.
Cancer Research
|
November 24, 2001
Increased p53 mutation frequency during tumor progression--results from a breast cancer cohort
T Norberg, S Klaar, G Kärf, et al.
Page
of 27